Dr. Talia Rosenberg Kaden, MD

Dr. Kaden practices at Manhattan Eye Ear and Throat Hospital in New York, New York.

Dr. Kaden's NPI, 1770825689, was assigned on March 19, 2013. Dr. Kaden graduated from Yale School of Medicine in 2011. Dr. Kaden holds New York license 287937.

Dr. Kaden's primary practice is Manhattan Eye Ear and Throat Hospital, at 210 E 64th St, New York, NY 10065 in New York County. The practice phone is (212) 434-4355.

Dr. Kaden's primary practice is Manhattan Eye Ear and Throat Hospital in New York, New York. Dr. Kaden is also affiliated with Lenox Hill Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Kaden to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaden practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Kaden's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Kaden is licensed in New York.

CMS data shows 15,544 Medicare services from Dr. Kaden across 11 procedure codes in 2024, for 620 Medicare patients. Medicare paid $597,696 for them. Every service was in an office.

CMS counts 620 Medicare patients who saw Dr. Kaden in 2024. The largest group is 75 to 84, with 258 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kaden's median patient age at 70, with 53% women.

In 2024, Dr. Kaden wrote 242 Medicare Part D claims for 80 patients. 54% of them were for generic drugs. CMS names the drug for 174 of them, across 4 drugs with 11 or more claims each, at $7,899 in total drug cost. In 2023, CMS named 164 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Kaden for performance year 2024, reported through an alternative payment model (APM). Dr. Kaden accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of cataract surgery by Dr. Kaden, more than 32% of the clinicians it reports for that procedure.

Dmand AI links 23 papers to Dr. Kaden, published from 2016 to 2025. 2018 was the busiest year, with 3. The most frequent topics are Fluorescein Angiography, Tomography, Optical Coherence and Visual Acuity. Dr. Kaden has published most often in Ophthalmic Surg Lasers Imaging Retina. Dr. Kaden's most frequent co-authors are Michael Engelbert, MD, Jennifer Oluyemisi Adeghate, MD, PhD and Gaetano R. Barile, MD.

CMS Open Payments shows 102 general payments to Dr. Kaden from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. Genentech, Inc. paid the most, $45,542. It also lists 2 research payments totaling $1,870 from 2023 to 2024, naming 1 clinical trial.

Dr. Kaden graduated from Yale School of Medicine in 2011.